Clinical Focus

• Cancer> Urologic Oncology
• Bladder Cancer - Urologic Oncology
• Bladder Cancer
• Kidney Cancer
• Penile Cancer

Administrative Appointments

• Clerkship Director, Urology (1998 - 2005)
• Program Director, Residency program (2006 - present)

Professional Education

Internet Links

• http:urology.stanford.edu

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

Benign Prostatic Hyperplasia- Evaluation of new minimally invasive techniques. HIFU and cryotherapy are being evaluated as a image guided minimally invasive technique for the treatment of symptomatic BPH

Clinical Trials

• Microarray Analysis of Gene Expression in Prostate Tissues Recruiting
• Prostate Active Surveillance Study (PASS) Recruiting
• Quality of Life Following Radical Prostatectomy Recruiting
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Completed
• Hypofractionated Radiotherapy for Localized Prostate Cancer (with CyberKnife or with IMRT) Completed

Publications

• MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia. Ghanouni P, Gill H, Kaye E, Pauly KB, Daniel B. J Vasc Interv Radiol. 2011; 22 (10): 1427-30
• Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Woo HH, Chin PT, McNicholas TA, Gill HS, Plante MK, Bruskewitz RC, Roehrborn CG. BJU Int. 2011; 108 (1): 82-8
• Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC). Harshman LC, Yu RJ, Allen GI, Srinivas S, Gill HS, Chung BI. Urol Oncol. 2011
• Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL. Proc Natl Acad Sci U S A. 2009; 106 (33): 14016-21
• Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases. Bosev D, Nicoll LM, Bhagan L, Lemyre M, Payne CK, Gill H, Nezhat C. J Urol. 2009; 182 (6): 2748-52